International companies in the biopharmaceutical industry trust IDT for its expertise, reliability and years of experience in the manufacture of prophylactic and therapeutic biologics. Many human vaccines developed by IDT together with international partners are already in use, fighting tuberculosis, AIDS and malaria. IDT has the capacity to manufacture live vaccines as recombinant vector vaccines, based on orthopoxvirus, for example, or as live attenuated virus vaccines.
IDT utilizes the latest, most advanced technologies in the production of these products. The company handles every step in manufacturing and quality control processes: bulk active substances, sterile filling, efficient packaging systems, cold chains, early development, small-batch production of samples and large-scale production.
In the field of pharmaceutical drugs, IDT focuses on sterile, injectable, bioengineered finished products. Here again, IDT Biologika handles the entire process chain, from development to ready-for-sale packaging of pharmaceutical products. The company employs highly efficient production technologies in the manufacturing of these advanced pharmaceuticals.
IDT Biologika specializes on the development and manufacture of sterile liquid drug products is one of the few companies worldwide, providing fully integrated industrialization services ranging from formulation process optimization and clinical manufacturing to large-scale production, packaging and quality control. The company has experience in technically sophisticated projects such as innovative biopharmaceuticals and lyophilized compounds manufactured in EMA and FDA-inspected facilities.